Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells
- 1 July 1996
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 58 (4), 395-401
- https://doi.org/10.1016/0960-0760(96)00048-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- EB1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitroBiochemical Pharmacology, 1992
- Effects of synthetic vitamin d analogues on breast cancer cell proliferation in vivo and in vitroBiochemical Pharmacology, 1992
- bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytesCell, 1991
- A Novel Vitamin D3Analog, 22-Oxa-1, 25- Dihydroxyvitamin D3, Inhibits the Growth of Human Breast Cancerin Vitroandin Vivowithout Causing Hypercalcemia*Endocrinology, 1991
- Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6Nature, 1991
- Programmed cell death: Apoptosis and oncogenesisCell, 1991
- Mammary gland 1, 25-dihydroxyvitamin D3 receptor content during pregnancy and lactationMolecular and Cellular Endocrinology, 1988
- Apoptosis: Cell death in tissue regulationThe Journal of Pathology, 1987